Medicines, Poisons and Therapeutic Goods Regulation 2008
584Medicines advisory committee—review of CHO decisions
Start here
Get a plain-English read of 584
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Regulation 2008.
584 Medicines advisory committee—review of CHO decisions to refuse endorsements to treat drug-dependency (1) This section applies if the chief health officer refuses under section 582 to give an endorsement to a designated prescriber. (2) The designated prescriber may, not later than 28 days after the day the designated prescriber receives written notice of the decision, apply to the medicines advisory committee for review of the decision. (a) must be in writing signed by the designated prescriber; and (c) may include any information that the designated prescriber considers appropriate for the review. (4) The medicines advisory committee may, in writing, ask the designated prescriber to give the committee further information that the committee reasonably needs to decide the application. (5) After considering the application and any further information provided in accordance with a notice under subsection (4), the medicines advisory committee must— (a) recommend that the chief health officer confirm the decision made; or (b) recommend that the chief health officer revoke the decision made and approve the application as recommended by the (6) A recommendation must be in writing.
use Note It is a condition of an authorisation to prescribe an ACT listed appendix D medicine for the prescriber to have an approval under this part (see s 31 (1) (e)).